Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
04/09

DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rallied 1.34% to $9.84 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.80% to 22,635.00 and the Dow Jones Industrial Average rising 2.85% to 47,909.92.

The stock's rise snapped a two-day losing streak.

Corbus Pharmaceuticals Holdings Inc. closed 52.14% below its 52-week high of $20.56, which the company reached on October 20th.

The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 2.15% to $7.29, Fortress Biotech Inc. (FBIO) fell 1.70% to $2.31, and Viking Therapeutics Inc. (VKTX) fell 0.09% to $33.67.

Trading volume (203,897) eclipsed its 50-day average volume of 198,991.

Data source: Dow Jones Market Data, FactSet. Data compiled April 8, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 08, 2026 17:19 ET (21:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10